Skip to main content
VCbacked
Log inGet Started

Allegria Therapeutics

Basel, Switzerland

Allegria Therapeutics is a biotech firm that engages in the research and treatment of allergy and mast cell-mediated inflammatory diseases.

$5.1M raised
Apr 2026
Grant
BiotechnologyHealth DiagnosticsLife ScienceTherapeutics

Top Investors

Forty51 VenturesLichtsteiner FoundationALK AbellóHighLight CapitalEureka Network

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Allegria Therapeutics

How much funding has Allegria Therapeutics raised?
Allegria Therapeutics has raised $5.1M in total funding. The most recent round was Grant. The last funding was announced in April 2026.
Who are Allegria Therapeutics's investors?
Allegria Therapeutics's investors include Forty51 Ventures, Lichtsteiner Foundation, ALK Abelló, HighLight Capital, Eureka Network.
Where is Allegria Therapeutics headquartered?
Allegria Therapeutics is headquartered in Basel, Switzerland.
What does Allegria Therapeutics do?
Allegria Therapeutics is a biotech firm that engages in the research and treatment of allergy and mast cell-mediated inflammatory diseases.
What stage is Allegria Therapeutics at?
Allegria Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Allegria Therapeutics — Funding & Investors." VCBacked, April 17, 2026, https://www.vcbacked.co/company/allegria-therapeutics. Accessed June 16, 2026.
APA
VCBacked. (2026). Allegria Therapeutics — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/allegria-therapeutics
Wikipedia (cite web)
{{cite web |title=Allegria Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/allegria-therapeutics |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong